Damien SENE

Professor

Université Paris Cité

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Damien Sene is a faculty member at Université Paris Cité in France. His recent research focuses on autoimmune diseases and their complications, particularly in the fields of uveitis and Sjögren’s syndrome. He has contributed significantly to the understanding of treatment outcomes for refractory conditions and the impact of COVID-19 in patients with underlying immune deficiencies.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Nihan Acar-Denizli

Tenure Track Lecturer (Serra Hunter)

Universitat Politècnica de Catalunya

SPAIN

View details

Gunnel Nordmark

Associate Professor, adjunct lecturer

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Damien SENE

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

Anti-Tumor Necrosis Factor alpha versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema A Multicenter Study from the French Uveitis Network

In vivo confocal microscopic study of corneal innervation in Sjogren?s Syndrome with or without small fiber neuropathy

Lower Relapses Rate With Inf liximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths

Childhood-onset of primary Sjogren's syndrome: phenotypic characterization at diagnosis of 158 children

Comment on: Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Collaborators (2)

Nihan Acar-Denizli

Gunnel Nordmark

Make your next move.